521 related articles for article (PubMed ID: 7642872)
1. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
[TBL] [Abstract][Full Text] [Related]
2. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
Terrosu P; Franceschino V; Contini GM; Dore L; Ibba GV
G Ital Cardiol; 1984 Jan; 14(1):63-6. PubMed ID: 6538527
[TBL] [Abstract][Full Text] [Related]
3. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy.
Paz R; Jortner R; Tunick PA; Sclarovsky S; Eilat B; Perez JL; Kronzon I
N Engl J Med; 1996 Sep; 335(13):938-41. PubMed ID: 8782501
[TBL] [Abstract][Full Text] [Related]
4. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
Nagashima J
J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
[TBL] [Abstract][Full Text] [Related]
5. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
[TBL] [Abstract][Full Text] [Related]
7. [Immediate hemodynamic response to atrioventricular+ stimulation in severe hypertrophic obstructive myocardiopathy].
Tascón Pérez JC; Albarrán A; Trevilla G; Alonso Gutiérrez M; Andreu Dussac J; Lombera Romero F; Escribano Subías P; Hernández Afonso J; Hernández Hernández F; Coma Samartín R; Rodríguez García J; García Cosío F
Rev Esp Cardiol; 1996 Nov; 49(11):815-22. PubMed ID: 9082492
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy.
Sasson Z; Rakowski H; Wigle ED
Cardiol Clin; 1988 May; 6(2):233-88. PubMed ID: 3066484
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
[TBL] [Abstract][Full Text] [Related]
10. [Complex hemodynamic analysis of left ventricular systole in hypertrophic cardiopathy--clinical implications].
Dabrowski M; Górecka B; Witkowski A; Ruzyłło W
Kardiol Pol; 1990; 33(5):288-302. PubMed ID: 2074625
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
Steendijk P; Meliga E; Valgimigli M; Ten Cate FJ; Serruys PW
Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of continuous intravenous drip infusion of disopyramide in hypertrophic obstructive cardiomyopathy during cardiogenic shock: a case report].
Kajimoto K; Harada T; Imamura K; Matsuda N; Niki K; Hagiwara N; Kasanuki H
J Cardiol; 2000 Mar; 35(3):197-203. PubMed ID: 10808427
[TBL] [Abstract][Full Text] [Related]
13. [Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy].
Emoto R; Yokota Y; Miki T; Usuki S; Miki T; Nomura H; Takeuchi Y; Nakatani M; Fukuzaki H
J Cardiol; 1991; 21(1):87-96. PubMed ID: 1817184
[TBL] [Abstract][Full Text] [Related]
14. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
[TBL] [Abstract][Full Text] [Related]
16. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.
Niki K; Sugawara M; Tanino S; Iwade K; Hosoda S; Kasanuki H
Heart Vessels; 1999; 14(2):72-81. PubMed ID: 10651183
[TBL] [Abstract][Full Text] [Related]
17. Effect of disopyramide on systolic and early diastolic time intervals in patients with hypertrophic cardiomyopathy.
Sumimoto T; Hamada M; Ohtani T; Shigematsu Y; Fujiwara Y; Sekiya M; Hiwada K
J Clin Pharmacol; 1991 May; 31(5):440-3. PubMed ID: 2050829
[TBL] [Abstract][Full Text] [Related]
18. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction.
Schaff HV; Dearani JA; Ommen SR; Sorajja P; Nishimura RA
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797
[TBL] [Abstract][Full Text] [Related]
19. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
Kimball BP; Bui S; Wigle ED
Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312
[TBL] [Abstract][Full Text] [Related]
20. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
Pollick C; Kimball B; Henderson M; Wigle ED
Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
